Quality of Vision in Implantable Collamer Lens (ICL)
Study Details
Study Description
Brief Summary
The aim of this study is to observe the influence of pupil size upon visual outcome in patients with Visian Implantable Collamer Lens(ICL) and toric-ICL implantation.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The aim of this study is to observe the influence of pupil size upon the quality of vision outcome in patients with Visian Implantable Collamer Lens(ICL) and toric-ICL implantation. Pre-operation and 3-month post-operation pupil size, visual acuity, quality of vision will be evaluated in patient that had ICL surgery.
Study Design
Outcome Measures
Primary Outcome Measures
- Subjective Quality of vision [Baseline (before surgery) and 3 month after surgery]
Change in QoV questionnaire score after ICL surgery at 3-month testing will be compare with baseline measurements
- Pupil diameter pre-operation and post-operation [Baseline (before surgery) and 3 month after surgery]
Change in Pupil diameter after ICL surgery at 3-month testing will be compare with baseline measurements
- Wave front aberrometry [baseline and 3 month after surgery]
Change in Wave front aberrometry after ICL surgery at 3-month testing will be compare with baseline measurements
- Point Spread Function (PSF) [baseline and 3 month after surgery]
Change in Point Spread Function (PSF) after ICL surgery at 3-month testing will be compare with baseline measurements
- Strehl ratio [Baseline and 3 month after surgery]
Change in Pupil diameter after ICL surgery at 3-month testing will be compare with baseline measurements
- Modulation transfer function (MTF) [Baseline and 3 month after surgery]
Change in Modulation transfer function after ICL surgery at 3-month testing will be compare with baseline measurements
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Myopic eyes
-
Preoperative corneal endothelial cell count ≥2200/mm2
-
Preoperative central anterior chamber depth> 2.80mm
-
Intraocular pressure within the normal range (10-21mmHg)
Exclusion Criteria:
-
Severe dry eye
-
Cataract and glaucoma
-
Patients with uveitis
-
Retinal detachment
-
Patients with autoimmune diseases
-
Patients with systemic diseases such as diabetes and hypertension
-
Patients with mental or cognitive abnormalities
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | He Eye Specialist Hospital, Shenyang. | Shenyang | Liaoning | China | 110141 |
Sponsors and Collaborators
- He Eye Hospital
Investigators
- Study Chair: Wei He, He Eye Specialist Hospital, Shenyang.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ICL2020